GlassScriptPhysician profile
Hemn H Qader
NPI 1952797490
$8,794.68
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $699 · 2023: $2,691 · 2024: $5,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,094 · Education: $2,500 · Food and Beverage: $2,487 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,093.98 |
| Education | $2,500.00 |
| Food and Beverage | $2,486.96 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,864.22 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,282.83 | 2023-2024 | Echelon Flex, Vistaseal |
| Medtronic, INC. | $1,139.33 | 2022-2024 | Signia, Ligasure, Sonicision |
| W. L. Gore & Associates, INC. | $263.84 | 2022-2023 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $104.19 | 2024 | Echelon Flex |
| Dilon Technologies, INC. | $85.64 | 2023 | Hemoblast Bellows |
| Davol INC. | $22.33 | 2024 | Phasix Mesh |
| Becton, Dickinson and Company | $18.13 | 2024 | Arista Ah Flexitip |
| Abbvie INC. | $14.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemn Qader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.